Free Trial
→ Elon Musk’s $1 Quadrillion AI IPO (From Brownstone Research) (Ad)tc pixel Free DMAC Stock Alerts

DiaMedica Therapeutics (DMAC) Short Interest Ratio & Short Volume

DiaMedica Therapeutics logo
$6.25 +0.20 (+3.31%)
Closing price 04:00 PM Eastern
Extended Trading
$6.25 0.00 (0.00%)
As of 05:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

DiaMedica Therapeutics Short Interest Overview

As of April 15, 2026, DiaMedica Therapeutics (DMAC) had a short interest of 4.77 million shares sold short, representing 9.32% of the public float. This marks a 4.05% increase in short interest since the prior report. The short interest ratio (days to cover) is 24.2, meaning it would take 24.2 days of the average trading volume of 207,068 shares to cover all short positions.

Current Short Interest
4,772,520 shares
Previous Short Interest
4,586,548 shares
Change Vs. Previous Month
4.05%
Dollar Volume Sold Short
$31.40 million
Short Interest Ratio
24.2 Days to Cover
Last Record Date
April 15, 2026
Outstanding Shares
53,883,000 shares
Short Percent of Float
9.32%
Today's Trading Volume
159,238 shares
Average Trading Volume
207,068 shares
Today's Volume Vs. Average
77%
Short Selling DiaMedica Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for DiaMedica Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

DMAC Short Interest Over Time

DMAC Days to Cover Over Time

DMAC Percentage of Float Shorted Over Time

DiaMedica Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20264,772,520 shares $31.40 million +4.1%9.3%24.16 $6.58
3/31/20264,586,548 shares $31.05 million +3.6%9.2%17.55 $6.77
3/13/20264,425,909 shares $32.22 million +6.7%9.2%22.74 $7.28
2/27/20264,146,534 shares $32.96 million -5.7%8.6%24.39 $7.95
2/13/20264,397,930 shares $37.51 million +5.7%9.1%25.46 $8.53
1/30/20264,162,424 shares $33.47 million -1.5%8.6%13.88 $8.04
1/15/20264,227,284 shares $36.10 million +3.3%8.8%21.38 $8.54
12/31/20254,093,770 shares $32.59 million -22.8%8.5%10.78 $7.96
12/15/20255,301,959 shares $45.97 million +0.9%11.0%10.71 $8.67
11/28/20255,254,769 shares $47.16 million +5.0%10.9%7.72 $8.98
11/14/20255,004,442 shares $29.68 million +21.5%10.4%13.43 $5.93
10/31/20254,119,047 shares $29.08 million +0.0%8.6%15.31 $7.06
10/15/20254,120,000 shares $29.05 million -2.8%8.6%11 $7.05
9/30/20254,240,000 shares $29.13 million +2.9%N/A10.6 $6.87
9/15/20254,120,000 shares $28.88 million +2.2%N/A9.2 $7.01
8/31/20254,030,000 shares $23.01 million +5.2%8.4%10.4 $5.71
8/15/20253,830,000 shares $23.09 million +16.8%N/A11.9 $6.03
7/31/20253,280,000 shares $13.84 million +36.1%6.8%11.6 $4.22
7/15/20252,410,000 shares $10.36 million +13.7%N/A10.5 $4.30
6/30/20252,120,000 shares $8.27 million +72.4%5.3%12.6 $3.90
6/15/20251,230,000 shares $4.49 million +11.8%3.1%11.2 $3.65
5/31/20251,100,000 shares $4.51 million +28.4%2.8%11.1 $4.10
5/15/2025856,900 shares $3.49 million +38.3%2.2%9.1 $4.07
4/30/2025619,700 shares $2.57 million +66.9%N/A6.8 $4.15
4/15/2025371,400 shares $1.30 million +1.4%0.9%4.3 $3.51
3/31/2025366,400 shares $1.39 million +38.7%0.9%4.1 $3.79
3/15/2025264,200 shares $1.52 million +4.2%0.7%3 $5.77
2/28/2025253,500 shares $1.66 million +9.1%0.6%2.8 $6.53
2/15/2025232,300 shares $1.46 million +21.1%0.6%2 $6.29
1/31/2025191,900 shares $1.11 million -8.4%N/A1.9 $5.76
1/15/2025209,500 shares $1.13 million -6.0%N/A2.1 $5.38
12/31/2024222,800 shares $1.21 million +14.5%N/A2.4 $5.43
12/15/2024194,600 shares $1.05 million +28.5%N/A2.2 $5.38
11/30/2024151,500 shares $857.49 thousand -12.2%N/A1.8 $5.66
11/15/2024172,500 shares $691.73 thousand -1.8%N/A2.4 $4.01
10/31/2024175,600 shares $767.37 thousand -4.2%N/A3.6 $4.37
10/15/2024183,300 shares $815.69 thousand +20.4%N/A3.5 $4.45
9/30/2024152,300 shares $638.14 thousand +10.0%N/A2.8 $4.19
9/15/2024138,400 shares $622.80 thousand -0.4%N/A1.9 $4.50
8/31/2024139,000 shares $546.27 thousand -2.1%N/A2.1 $3.93
8/15/2024142,000 shares $498.42 thousand -1.5%N/A2.3 $3.51
7/31/2024144,200 shares $472.98 thousand -17.0%N/A2.4 $3.28
7/15/2024173,700 shares $621.85 thousand +10.8%N/A3 $3.58
6/30/2024156,800 shares $462.56 thousand +22.1%N/A2.7 $2.95
6/15/2024128,400 shares $308.16 thousand -1.9%N/A3.5 $2.40
5/31/2024130,900 shares $379.61 thousand +1.8%N/A3.5 $2.90
5/15/2024128,600 shares $387.09 thousand -29.3%N/A3.3 $3.01
4/30/2024182,000 shares $469.56 thousand +3.8%N/A4.3 $2.58
4/15/2024175,400 shares $419.21 thousand -13.3%N/A4.4 $2.39
3/31/2024202,200 shares $560.09 thousand -4.9%N/A4.8 $2.77
3/15/2024212,600 shares $644.18 thousand +8.3%N/A5 $3.03
2/29/2024196,300 shares $588.90 thousand +3.7%N/A4.7 $3.00
2/15/2024189,300 shares $567.90 thousand -3.3%N/A4.4 $3.00
1/31/2024195,700 shares $551.87 thousand -3.1%N/A4 $2.82
1/15/2024202,000 shares $603.98 thousand +7.0%N/A4 $2.99
12/31/2023188,800 shares $536.19 thousand -2.2%N/A3.8 $2.84
12/15/2023193,100 shares $531.03 thousand +5.4%N/A3.7 $2.75
11/30/2023183,300 shares $447.25 thousand -24.9%N/A3.1 $2.44
11/15/2023244,200 shares $598.29 thousand 0.0%N/A4 $2.45
10/31/2023244,300 shares $532.57 thousand +11.5%N/A4 $2.18
10/15/2023219,100 shares $449.16 thousand -1.1%N/A2.9 $2.05
9/30/2023221,500 shares $571.47 thousand +0.7%N/A2.3 $2.58
9/15/2023219,900 shares $712.48 thousand -0.8%N/A1.8 $3.24
8/31/2023221,700 shares $654.02 thousand -9.4%N/A1.5 $2.95
8/15/2023244,600 shares $725.24 thousand -10.6%N/A1.5 $2.97
7/31/2023273,500 shares $924.43 thousand -65.7%N/A1.6 $3.38
7/15/2023796,100 shares $3.01 million +11.6%4.5%5.4 $3.78
6/30/2023713,600 shares $3.08 million +910.8%4.0%5.4 $4.32
6/15/202370,600 shares $224.51 thousand +7.1%0.4%0.7 $3.18
5/31/202365,900 shares $179.91 thousand -21.2%0.4%1.1 $2.73
5/15/202383,600 shares $166.20 thousand -9.0%0.5%1.9 $1.99
4/30/202391,900 shares $149.80 thousand -5.7%0.5%3.4 $1.63
4/15/202397,400 shares $155.84 thousand +6.5%0.6%3.4 $1.60
3/31/202391,500 shares $140.00 thousand +55.6%0.5%2.9 $1.53
3/15/202358,800 shares $104.66 thousand +44.8%0.4%1.5 $1.78
2/28/202340,600 shares $70.24 thousand -1.7%0.3%0.7 $1.73
2/15/202341,300 shares $62.36 thousand +22.6%0.3%0.7 $1.51
1/31/202333,700 shares $45.50 thousand -57.8%0.2%0.5 $1.35
1/15/202379,800 shares $130.87 thousand -6.5%0.5%1.2 $1.64
12/30/202285,300 shares $134.78 thousand +113.8%0.5%1.3 $1.58
12/15/202239,900 shares $60.25 thousand -7.0%0.2%0.6 $1.51
11/30/202242,900 shares $51.05 thousand +24.4%0.2%0.7 $1.19
11/15/202234,500 shares $39.33 thousand -35.0%0.2%0.6 $1.14
10/31/202253,100 shares $62.66 thousand -47.5%0.3%0.9 $1.18
10/15/2022101,200 shares $153.82 thousand +245.4%0.6%1.9 $1.52
9/30/202229,300 shares $36.33 thousand -61.7%0.2%0.4 $1.24
9/15/202276,500 shares $110.93 thousand +153.3%0.4%0.5 $1.45
8/31/202230,200 shares $53.45 thousand -43.6%0.2%0.2 $1.77
8/15/202253,500 shares $96.84 thousand -0.2%0.3%0.4 $1.81
7/31/202253,600 shares $88.44 thousand +10.7%0.3%0.4 $1.65
7/15/202248,400 shares $61.95 thousand -8.2%0.3%0.4 $1.28
6/30/202252,700 shares $106.45 thousand +5.0%0.3%0.4 $2.02
6/15/202250,200 shares $110.44 thousand -1.6%0.3%1.1 $2.20
5/31/202251,000 shares $123.93 thousand -50.3%N/A1.2 $2.43
5/15/2022102,700 shares $250.59 thousand +85.4%N/A2.3 $2.44
4/30/202255,400 shares $128.53 thousand +62.5%N/A1.2 $2.32
4/15/202234,100 shares $79.11 thousand +5.9%N/A0.6 $2.32
3/31/202232,200 shares $80.50 thousand -45.8%N/A0.5 $2.50
3/15/202259,400 shares $136.62 thousand -26.0%N/A0.7 $2.30
2/28/202280,300 shares $211.19 thousand -23.5%N/A0.7 $2.63
2/15/2022104,900 shares $325.19 thousand +21.6%N/A0.9 $3.10
1/31/202286,300 shares $223.52 thousand +14.9%0.5%0.6 $2.59
1/15/202275,100 shares $253.84 thousand +22.1%0.4%0.4 $3.38
12/31/202161,500 shares $229.40 thousand -22.5%0.3%0.4 $3.73
12/15/202179,300 shares $307.68 thousand +55.8%0.4%0.4 $3.88
11/30/202150,900 shares $190.37 thousand -26.9%0.3%0.3 $3.74
11/15/202169,600 shares $280.49 thousand -21.5%0.4%0.3 $4.03
10/29/202188,700 shares $350.37 thousand -7.9%0.6%0.4 $3.95
10/15/202196,300 shares $394.83 thousand +62.4%0.6%0.5 $4.10
9/30/202159,300 shares $237.79 thousand +9.6%N/A0.3 $4.01
9/15/202154,100 shares $209.37 thousand +29.7%0.3%0.2 $3.87
8/31/202141,700 shares $179.31 thousand +85.3%0.2%0.1 $4.30
8/13/202122,500 shares $69.75 thousand -59.4%0.1%0.1 $3.10
7/30/202155,400 shares $191.13 thousand -23.9%0.3%0.2 $3.45
7/15/202172,800 shares $264.99 thousand -47.5%0.4%0.3 $3.64
6/30/2021138,700 shares $617.22 thousand -26.9%0.8%0.6 $4.45
6/15/2021189,800 shares $1.64 million +27.7%1.1%1.9 $8.63
5/28/2021148,600 shares $1.10 million -6.8%0.9%1.6 $7.41
5/14/2021159,400 shares $1.03 million -2.8%N/A1.5 $6.47

DMAC Short Interest - Frequently Asked Questions

What is DiaMedica Therapeutics' current short interest?

Short interest is the volume of DiaMedica Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 4,772,520 shares of DMAC short. 9.32% of DiaMedica Therapeutics' shares are currently sold short. Learn More on DiaMedica Therapeutics' current short interest.

What is a good short interest ratio for DiaMedica Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DMAC shares currently have a short interest ratio of 24.2. Learn More on DiaMedica Therapeutics's short interest ratio.

Which institutional investors are shorting DiaMedica Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of DiaMedica Therapeutics: Group One Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for DiaMedica Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.32% of DiaMedica Therapeutics' floating shares are currently sold short.

Is DiaMedica Therapeutics' short interest increasing or decreasing?

DiaMedica Therapeutics saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 4,772,520 shares, an increase of 4.1% from the previous total of 4,586,548 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does DiaMedica Therapeutics' short interest compare to its competitors?

9.32% of DiaMedica Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to DiaMedica Therapeutics: WAVE Life Sciences Ltd. (9.33%), Corvus Pharmaceuticals, Inc. (19.30%), Olema Pharmaceuticals, Inc. (17.74%), Maze Therapeutics, Inc. (7.64%), Jade Biosciences, Inc. (8.27%), AbCellera Biologics Inc. (22.13%), MoonLake Immunotherapeutics (10.54%), Compass Pathways PLC Sponsored ADR (8.89%), Pharming Group N.V. Sponsored ADR (0.01%), Urogen Pharma (20.12%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($87.50 billion), Invesco QQQ ($42.26 billion), iShares Russell 2000 ETF ($24.79 billion), Salesforce Inc. ($13.16 billion), SPDR S&P Biotech ETF ($10.01 billion), Western Digital Corporation ($9.77 billion), Sandisk Corporation ($8.69 billion), iShares 20+ Year Treasury Bond ETF ($8.06 billion), CoreWeave Inc. ($7.67 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($7.64 billion). View all of the most shorted stocks.

What does it mean to sell short DiaMedica Therapeutics stock?

Short selling DMAC is an investing strategy that aims to generate trading profit from DiaMedica Therapeutics as its price is falling. DMAC shares are trading up $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against DiaMedica Therapeutics?

A short squeeze for DiaMedica Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DMAC, which in turn drives the price of the stock up even further.

How often is DiaMedica Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DMAC, twice per month. The most recent reporting period available is April, 15 2026.

What do DMAC's short interest metrics mean?

Understanding short interest metrics can help you assess how traders are positioning around a stock like DMAC:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Related Companies
Short Interest Tools

This page (NASDAQ:DMAC) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel